Literature DB >> 18837703

Uncommon presentation of mycosis fungoides: eyelid margin involvement.

Ulker Gül1, Seçil Soylu, Erkan Aslan, Zeliha Yazar, Murat Demiriz.   

Abstract

Mycosis fungoides is a cutaneous T-cell lymphoma that has been rarely reported to involve ocular structures. A 33-year-old woman who had received therapy for mycosis fungoides on the trunk for 11 years, presented to our clinic with new plaques and tumors on her eyebrows and eyelid margin, and alopecia of her eyelashes and eyebrow. The histopathological examinations supported the diagnosis of mycosis fungoides. There was no intraocular involvement with tumor. The mycosis fungoides was of stage II B, and the patient was referred to medical oncology and radiation oncology clinics for treatment. She was placed on a radiotherapy schedule. The involvement of mycosis fungoides in the ocular area is rare in the published work. The importance of eye involvement is being seen in advanced cases, and there is a possible association between mycosis fungoides and poor prognosis by being an indicator of systemic involvement.

Entities:  

Mesh:

Year:  2008        PMID: 18837703     DOI: 10.1111/j.1346-8138.2008.00526.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  3 in total

1.  [Retinal manifestation in hematological diseases].

Authors:  M Rehak; N Feltgen; P Meier; P Wiedemann
Journal:  Ophthalmologe       Date:  2018-09       Impact factor: 1.059

2.  Incidental folliculotropic mycosis fungoides in a blepharoplasty specimen performed for dermatochalasis.

Authors:  H S Mudhar; N Tiffin; Z Currie; S Salvi
Journal:  Eye (Lond)       Date:  2014-01-10       Impact factor: 3.775

3.  Ultrasound-guided microwave ablation as a palliative treatment for mycosis fungoides eyelid involvement: A case report.

Authors:  Yan-Wei Chen; Hai-Zhen Yang; Shuang-Shuang Zhao; Zheng Zhang; Zhe-Ming Chen; Hua-Hui Feng; Mao-Hui An; Ke-Ke Wang; Ran Duan; Bao-Ding Chen
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.